Semi-finished Oral Steroid Liquid Anastrozole Arimidex 5mg/ml
Product Details:
| Arimidex 5 Information | ||
| Arimidex 5 Price | 100ml | According to your needs |
| 500ml | According to your needs | |
| 1000ml | According to your needs | |
| Steroid packaging | Special stealth packaging through Customs | |
| Delivery time | About 7 days | |
| Shipping | EMS, Hongkong Post, DHL, TNT, Fedex | |
| Payment terms | WU, MG, Bitcoin, T/T | |
| Minimum order | 100ml liquid | |
Semi-finished Oral Steroid Liquid Anastrozole Arimidex 5mg/ml
Oral Anastrozole (Arimidex) Specifications:
COA
| Items | Standard | Results |
| Description | White crystalline powder | Complies |
| Identification | IR HPLC Reactive | Conform with standard IR Conform with standard HPLC Conform |
| Solubility | Freely soluble in methanol, acetone,ethanol and tetrahydrofuran. And very soluble in acetonitrile | Complies |
| Total Impurity | max.0.5% | 0.18% |
| Total Unspecified Impurity | max. 0.2% | 0.08% |
| Individual unspecified impurlty | max. 0.1% | 0.05% |
| Related compound B | max. 0.2% | 0.07% |
| Related compound C | max. 0.2% | 0.04% |
| Related compound D | max. 0.1% | 0.05% |
| Related compound E | max. 0.1% | 0.06% |
| Limit of cyclohexane | max. 0.08% | ND |
| Limit of ethylacetate | max. 0.1% | 0.07% |
| Melting point | 81.0~84.0ºC | 82.5~83.2ºC |
| Water | max. 0.3% | 0.21% |
| Residue on ignition | max. 0.1% | 0.07% |
| Heavy Metals | max.0.001% | Complies |
| Assay(HPLC) | 98.0%~102.0% | 99.3% |
| Storage | Cool and dry | |
| Conclusion | It complies to USP32 . | |
Oral Anastrozole (Arimidex) Descriptions:
Arimidex is the aromatase inhibitor of choice. Arimidex's mechanism of action - blocking conversion of aromatizable steroids to estrogen - is in contrast to the mechanism of action of anti-estrogens such as clomiphene (Clomid) or (Nolvadex), which block estrogen receptors in some tissues, and activate estrogen receptors in others.
Oral Anastrozole (Arimidex) Uasges:
An aromatase inhibitor. Used as an antineoplastic raw materials.
Potent selective triazole aromatase inhibitors, can inhibit the cytochrome P-450 aromatase enzyme which depends blocking the biosynthesis of estrogen, and estrogen to stimulate breast cancer cell growth factors. Treatment of breast cancer, especially for those with hormone relapse after adjuvant therapy after menopause for women with advanced breast cancer.
